Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adding G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic

NCT05222009 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT05222009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05222009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adding G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic
Lead sponsor
Sun Yat-sen University
Phase
Phase 1
Overall status
Unknown status
Start date
January 24, 2022
Completion date
August 1, 2023
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

granulocyte colony-stimulating factor, pd-1 inhibitor